Starboard Delivers Letter to Depomed Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/4/2026
- S&P 500, Dow hit record highs on strong AI-linked earnings, Mideast deal hopes
- Caterpillar stock jumps on strong earnings and revenue beat
- Optical component stocks rally on proposed U.S. ban on Chinese tech
- BofA says this memory stock could double. Here are 5 reasons why
- Merck shares rise on big Q2 earnings beat, adjusted FY outlook
- Palantir posts 93% revenue growth in Q2 2026, raises full-year outlook
- Nutanix to cut 5% of workforce, expects up to $43M in charges
- Grainger CFO resigns, interim replacement named
- Microsoft joins, Broadcom exits Goldman's top-stocks list
- Walmart dips after Oppenheimer downgrades shares on difficult short-term setup
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
DepoMed (DEPO): Raising PT On Increasing Likelihood Of A Sale - Mizuho
May 27, 2016 7:05 AM EDTMizuho analyst, Irina Koffler, is raising her PT on DepoMed Inc (NASDAQ: DEPO) to $23 from $19 on increased sale probability and expectations of a higher takeout valuation as Starboard involvement escalates. No change to Buy rating.
"After market, Starboard filed its proxy solicitation to... More
Depomed (DEPO) Issues Response to Starboard; Surprised About Public Solicitation Plans
May 26, 2016 11:19 AM EDTDepomed, Inc. (Nasdaq: DEPO) issued the following statement in response to Starboard Value LPs (Starboard) latest press release.
Over four weeks ago, in response to Starboards first request for a record date to call a special meeting, Depomed amended its now terminated shareholder rights plan to lower the trigger to 9.9% to allow Starboard to call a special meeting. Furthermore, we expressly communicated to Starboard that, recognizing Starboards reported status as a 9.9% shareholder, Depomed was prepared to... More
